Eydelman Mikhail
Known title: SVP, Gen Counsel & Corp SecCIK: 0001918033
Associated companies
Transaction History
| PCVX | ▼ Sell | Open Market | 112 | $8K | 3/5/2025 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 5,000 | $107K | 3/5/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,621 | $184K | 3/5/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,267 | $161K | 3/5/2025 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 616 | $44K | 3/3/2025 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 470 | $34K | 2/28/2025 | View on chart |
| PCVX | ▲ Buy | Grant | 14,484 | $0 | 2/27/2025 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 5,000 | $107K | 2/5/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 571 | $50K | 2/5/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 635 | $57K | 2/5/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,755 | $158K | 2/5/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,784 | $162K | 2/5/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 255 | $23K | 2/5/2025 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 5,000 | $107K | 1/6/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 954 | $81K | 1/6/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 3,921 | $336K | 1/6/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 125 | $11K | 1/6/2025 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 475 | $44K | 12/9/2024 | View on chart |
| PCVX | ▼ Sell | Gift | 110 | $0 | 12/5/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 5,000 | $107K | 12/5/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,435 | $129K | 12/5/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 3,177 | $292K | 12/5/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 388 | $36K | 12/5/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 5,000 | $107K | 11/5/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 788 | $83K | 11/5/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,415 | $150K | 11/5/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,524 | $163K | 11/5/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,273 | $137K | 11/5/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 5,000 | $107K | 10/7/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 476 | $51K | 10/7/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 996 | $108K | 10/7/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 3,147 | $345K | 10/7/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 314 | $35K | 10/7/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 67 | $7K | 10/7/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 5,500 | $118K | 10/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,414 | $160K | 10/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 3,056 | $350K | 10/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,030 | $118K | 10/1/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 1,667 | $36K | 9/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 4 | $431 | 9/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 523 | $58K | 9/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 715 | $80K | 9/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 122 | $14K | 9/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 79 | $9K | 9/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 144 | $17K | 9/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 80 | $9K | 9/3/2024 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 2,203 | $243K | 9/3/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 1,667 | $36K | 8/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 185 | $15K | 8/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,482 | $117K | 8/1/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 1,667 | $36K | 7/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 913 | $69K | 7/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 754 | $58K | 7/1/2024 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 335 | $24K | 6/7/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 1,667 | $36K | 6/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 751 | $54K | 6/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 656 | $47K | 6/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 260 | $19K | 6/3/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 1,667 | $36K | 5/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 964 | $59K | 5/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 559 | $35K | 5/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 144 | $9K | 5/1/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 1,667 | $36K | 4/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,397 | $93K | 4/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 270 | $18K | 4/1/2024 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 613 | $44K | 3/2/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 1,667 | $36K | 3/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 519 | $38K | 3/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 703 | $52K | 3/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 445 | $33K | 3/1/2024 | View on chart |
| PCVX | ▲ Buy | Grant | 10,500 | $0 | 2/29/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 1,667 | $36K | 2/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 212 | $15K | 2/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 638 | $47K | 2/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 343 | $25K | 2/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 474 | $36K | 2/1/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 1,667 | $36K | 1/2/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 141 | $9K | 1/2/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 598 | $38K | 1/2/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 928 | $60K | 1/2/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 10,000 | $565K | 12/7/2023 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 10,000 | $214K | 12/7/2023 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 325 | $18K | 12/7/2023 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 20,000 | $428K | 10/2/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 7,992 | $396K | 10/2/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 4,874 | $245K | 10/2/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 7,134 | $367K | 10/2/2023 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 1,189 | $61K | 9/5/2023 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 645 | $33K | 6/7/2023 | View on chart |
| PCVX | ▲ Buy | Grant | 13,750 | $0 | 3/1/2023 | View on chart |
| PCVX | ▲ Buy | Grant | 7,500 | $0 | 6/7/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Vaxcyte VAX-31 clears Phase III OPUS-1 trial endpoints
Vaxcyte announced that its VAX-31 vaccine met all primary endpoints in the pivotal Phase III OPUS-1 trial. This positive data point positions the company for additional readouts expected in the first half of 2027. The stock is currently trading near its 52-week high, reflecting strong market interest in the clinical progress.
Vaxcyte VAX-31 clears Phase III OPUS-1 trial endpoints. Vaxcyte announced that its VAX-31 vaccine met all primary endpoints in the pivotal Phase III OPUS-1 trial. This positive data point positions the company for additional readouts expected in the first half of 2027. The stock is currently trading near its 52-week high, reflecting strong market interest in the clinical progress.